🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

PAncreatic Disease Cohort of TOuLouse

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Toulouse
NCT05824403 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with inflammatory or cystic exocrine pancreatic pathology * Patient able to read and understand the information leaflet * Patients who have agreed to participate in the study and have signed the free and informed consent * Patients affiliated to a social security system (including AME) Exclusion Criteria: * Patient with pancreatic cancer pathology * Patients with active cancer, whatever the origin * Pregnant or breastfeeding patients * Patients under legal protection, guardianship or trusteeship
💊

What it tests

  • Not listed
📍

Where

1 site
Rangueil hospital
Toulouse, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy